MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: SkinBioTherapeutics raises £4 million for Superdrug deal

ALN

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Raises £4.2 million from the sale of 24.7 million new shares at 17 pence each. This is split between 24.1 million shares sold via placing and subscription, and 587,191 sold in an offer to retail investors. SkinBioTherapeutics announced the equity raise on Monday, saying it is to support an exclusive commercial agreement with Superdrug Stores PLC to roll-out AxisBiotix food supplements across the UK. The supplements are meant to alleviate inflammatory skin conditions.

Current stock price: 16.75p for £39.2 million market capitalisation

12-month change: up 72%

Copyright 2025 Alliance News Ltd. All Rights Reserved.